Ombudsman and Superman
Attention has frequently been drawn to the complexities of getting anything done in Europe. A brilliant researcher can explore visionary horizons, an ambitious entrepreneur can offer a package of goods...
View ArticleFraming the argument
The European debate about combating counterfeit medicines is generating a lot of heat in Brussels as it comes to a head. In March the European Parliament is starting to tackle the detail of the...
View ArticleClinical Trials: Can the EU Backtrack Fast Enough?
They may be well-meaning, but sometimes the EU’s decisions can have harmful effects, as is the case with its much criticized clinical trials directive. The furore over European Union rules created by...
View ArticlePatients Wade into the European Pricing Debate
An important third party is struggling to make its voice heard in European pharma discussions. Drug pricing is not just a matter of manufacturers battling with health ministries, insist groups...
View Article
